BUTORPHANOL TARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butorphanol Tartrate, and what generic alternatives are available?
Butorphanol Tartrate is a drug marketed by Baxter Hlthcare Corp, Hikma, Hikma Farmaceutica, Hospira, Apotex, and Rising. and is included in fourteen NDAs.
The generic ingredient in BUTORPHANOL TARTRATE is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Butorphanol Tartrate
A generic version of BUTORPHANOL TARTRATE was approved as butorphanol tartrate by HIKMA on August 12th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUTORPHANOL TARTRATE?
- What are the global sales for BUTORPHANOL TARTRATE?
- What is Average Wholesale Price for BUTORPHANOL TARTRATE?
Summary for BUTORPHANOL TARTRATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 7 |
| Patent Applications: | 4,407 |
| Drug Prices: | Drug price information for BUTORPHANOL TARTRATE |
| DailyMed Link: | BUTORPHANOL TARTRATE at DailyMed |
Recent Clinical Trials for BUTORPHANOL TARTRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanghai Zhongshan Hospital | N/A |
| Jiangsu Hengrui Pharmaceutical Co., Ltd. | Phase 4 |
| The First Affiliated Hospital with Nanjing Medical University | Phase 4 |
Pharmacology for BUTORPHANOL TARTRATE
| Drug Class | Opioid Agonist/Antagonist |
| Mechanism of Action | Competitive Opioid Antagonists Partial Opioid Agonists |
Medical Subject Heading (MeSH) Categories for BUTORPHANOL TARTRATE
Anatomical Therapeutic Chemical (ATC) Classes for BUTORPHANOL TARTRATE
US Patents and Regulatory Information for BUTORPHANOL TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | BUTORPHANOL TARTRATE | butorphanol tartrate | INJECTABLE;INJECTION | 075697-001 | Oct 23, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | BUTORPHANOL TARTRATE PRESERVATIVE FREE | butorphanol tartrate | INJECTABLE;INJECTION | 074626-001 | Jan 23, 1997 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | BUTORPHANOL TARTRATE | butorphanol tartrate | INJECTABLE;INJECTION | 075559-001 | Mar 20, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Farmaceutica | BUTORPHANOL TARTRATE | butorphanol tartrate | INJECTABLE;INJECTION | 078247-001 | Apr 29, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | BUTORPHANOL TARTRATE | butorphanol tartrate | SPRAY, METERED;NASAL | 075759-001 | Aug 8, 2001 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | BUTORPHANOL TARTRATE PRESERVATIVE FREE | butorphanol tartrate | INJECTABLE;INJECTION | 074620-002 | Jan 22, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
